Pemigatinib for Cholangiocarcinoma with FGFR2 Fusions or Rearrangements

Discussion Board › Forums › Websites › Pemigatinib for Cholangiocarcinoma with FGFR2 Fusions or Rearrangements

Viewing 2 posts - 1 through 2 (of 2 total)
  • Author
    Posts
  • July 16, 2022 at 4:07 am #101830
    gavin
    Moderator

    Apols, here is the link!

    Gavin

    July 16, 2022 at 4:07 am #101829
    gavin
    Moderator

    Hi all,

    Please have a listen to this podcast.

    Pemigatinib for Cholangiocarcinoma with FGFR2 Fusions or Rearrangements

    Arndt Vogel, MD, shares results from the phase 2, FIGHT-202 trial which evaluated pemigatinib in patients with previously treated, locally advanced or metastatic cholangiocarcinoma.

    Thanks all,

    Gavin

  • Author
    Posts
Viewing 2 posts - 1 through 2 (of 2 total)
  • The forum ‘Websites’ is closed to new topics and replies.